SLCO1B1 variants as predictors of methotrexate-related toxicity in children with juvenile idiopathic arthritis.

Conclusion: SLCO1B1 rs4149056 may serve as a determinant of MTX treatment toxicity in children with JIA.
PMID: 33025831 [PubMed - as supplied by publisher]

Source: Scandinavian Journal of Rheumatology - October 7, 2020 Category: Rheumatology Authors: Roszkiewicz J, Michałek D, Ryk A, Swacha Z, Szmyd B, Smolewska E Tags: Scand J Rheumatol Source Type: research